Experimental traumatic head injury (TBI) causes diffuse neuronal depolarization which produces a large non-specific release of neurotransmitters. the acute, net effect of TBI-induced agonist-receptor interactions is excessive neuronal excitation. The resulting excitoxicity significantly contributes to the pathophysiology of TBI. this process occurs even though inhibitory receptors (opioid, etc.) are also activated by injury. Our central hypothesis states that activation of brain opioid receptors at the time of injury can modulate acute TBI-induced processes which result in functional deficits persisting long after the initial insult. We propose to assess the effects of a single administration of selective opioid receptor subtype agonists or antagonists on outcome measures assessed days or even weeks after drug administration. Preliminary data suggest that pre-injury administration of mu or delta receptor subtype agonists reduces long-term function deficits associated with TBI. Conversely, other preliminary data suggest that pre-injury administration of selective mu or delta antagonists exacerbate TBI long- term functional deficits. Other studies suggest that activation of kappa receptors exacerbate TBI pathophysiology. Opioid receptors have inhibitory effects on neuronal excitability in most brain regions. However, in the hippocampus activation of certain opioid receptor subtypes increase neuronal excitability through a process of disinhibition. Thus, opioid receptor activation may either reduce or increase pathophysiological responses to TBI depending upon the anatomical location and subclass of opioid receptor affected. We will examine opioid mechanisms mediating TBI by examining the effects of selective mu, delta, and kappa opioid agonists and antagonists on TBI pathophysiology. We will examine drug effects on TBI-induced:increases in hippocampal excitability, increased vulnerability (neuronal death) to an imposed secondary ischemia, decreases in cerebral blood flow, and functional deficits. This research will provide important information on possible toxic and therapeutic effects of opioids necessary for any potential clinical application of such drugs.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
5R01NS029995-03
Application #
2268067
Study Section
Neurology A Study Section (NEUA)
Project Start
1992-07-01
Project End
1996-06-30
Budget Start
1994-07-01
Budget End
1995-06-30
Support Year
3
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Virginia Commonwealth University
Department
Surgery
Type
Schools of Medicine
DUNS #
City
Richmond
State
VA
Country
United States
Zip Code
23298
Shahlaie, Kiarash; Gurkoff, Gene G; Lyeth, Bruce G et al. (2013) Neuroprotective effects of SNX-185 in an in vitro model of TBI with a second insult. Restor Neurol Neurosci 31:141-53
Gurkoff, Gene G; Feng, Jun-Feng; Van, Ken C et al. (2013) NAAG peptidase inhibitor improves motor function and reduces cognitive dysfunction in a model of TBI with secondary hypoxia. Brain Res 1515:98-107
Gurkoff, Gene G; Shahlaie, Kiarash; Lyeth, Bruce G (2012) In vitro mechanical strain trauma alters neuronal calcium responses: Implications for posttraumatic epilepsy. Epilepsia 53 Suppl 1:53-60
Feng, Jun-feng; Zhao, Xueren; Gurkoff, Gene G et al. (2012) Post-traumatic hypoxia exacerbates neuronal cell death in the hippocampus. J Neurotrauma 29:1167-79
Feng, Jun-Feng; Gurkoff, Gene G; Van, Ken C et al. (2012) NAAG peptidase inhibitor reduces cellular damage in a model of TBI with secondary hypoxia. Brain Res 1469:144-52
Beller, Justin A; Gurkoff, Gene G; Berman, Robert F et al. (2011) Pharmacological enhancement of glutamate transport reduces excitotoxicity in vitro. Restor Neurol Neurosci 29:331-46
Feng, Jun-Feng; Van, Ken C; Gurkoff, Gene G et al. (2011) Post-injury administration of NAAG peptidase inhibitor prodrug, PGI-02776, in experimental TBI. Brain Res 1395:62-73
Fedor, Mark; Berman, Robert F; Muizelaar, J Paul et al. (2010) Hippocampal ? dysfunction after lateral fluid percussion injury. J Neurotrauma 27:1605-15
Shahlaie, Kiarash; Lyeth, Bruce G; Gurkoff, Gene G et al. (2010) Neuroprotective effects of selective N-type VGCC blockade on stretch-injury-induced calcium dynamics in cortical neurons. J Neurotrauma 27:175-87
Zhang, Bin; West, Eric J; Van, Ken C et al. (2008) HDAC inhibitor increases histone H3 acetylation and reduces microglia inflammatory response following traumatic brain injury in rats. Brain Res 1226:181-91

Showing the most recent 10 out of 44 publications